Início › Câncer de Pulmão › Illinois › Cicero
Ensaios clínicos de Câncer de Pulmão em Cicero, IL
17 estudos para Câncer de Pulmão estão buscando participantes em locais em Cicero e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- OSF Little Company of Mary Medical Center, Evergreen Park · a 9 mi de distância
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecrutandoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecrutandoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecrutandoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RecrutandoFase 2
- Hope and Healing Clinical Research, Hinsdale · a 10 mi de distância
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Hope and Healing Cancer Services, Hinsdale · a 10 mi de distância
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RecrutandoFase 2
- Hope and Healing Clinical Research, Hinsdale · a 10 mi de distância
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecrutandoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- Hope and Healing Cancer Services, Hinsdale · a 10 mi de distância
- Endeavor Health, Elmhurst · a 10 mi de distância
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecrutandoFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi de distância
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecrutandoFase 3
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- Advocate High Tech Medical Park, Palos Heights · a 12 mi de distância
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · a 3 mi de distância
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Loyola University Medical Center, Maywood · a 5 mi de distância
- e mais 2
MYLUNG Consortium Part 3: Observational Study
RecrutandoEstudo observacional
- Affiliated Oncologists, LLC, Chicago Ridge · a 10 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Edward Hines Jr VA Hospital, Hines · a 4 mi de distância
- Loyola University Medical Center, Maywood · a 5 mi de distância
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Loyola University Medical Center, Maywood · a 5 mi de distância
- Northwestern Medicine Oak Brook, Oak Brook · a 9 mi de distância
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- e mais 2
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recrutando
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · a 4 mi de distância
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RecrutandoEstudo observacional
- Advocate Christ Medical Center, Oak Lawn · a 9 mi de distância
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · a 9 mi de distância
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Washington, DC41 estudos
- Arlington, VA41 estudos
- Chicago, IL41 estudos
- Nashville, TN40 estudos
- Baltimore, MD40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em Cicero
- Câncer de Pulmão de Não Pequenas Células24 estudos
- Câncer de Próstata14 estudos
- Câncer (todos os tipos)13 estudos
- Leucemia Mieloide Aguda11 estudos
- Câncer de Mama11 estudos
- Câncer Colorretal10 estudos
- Câncer de Bexiga8 estudos
- Câncer Metastático7 estudos
- Melanoma7 estudos
- Doença Cardiovascular7 estudos
- Linfoma de Burkitt6 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço6 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.